SEARCH

SEARCH BY CITATION

References

  • 1
    Greif F, Bronsther O, Van Thiel D, Casavilla A, Iwatsuki S, Tzakis A, et al. The incidence, timing and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994; 219:4045. MEDLINE
  • 2
    Vallera R, Cotton P, Clavien P. Biliary reconstruction for liver transplantation and management of biliary complications: Overview and survey of current practices in the United States. Liver Transpl Surg 1995; 2:333335.
  • 3
    Stratta RJ, Wood RP, Langnas AN, Hollins RR, Bruder KJ, Donovan JP, et al. Diagnosis and treatment of biliary tract complications after orthotopic liver transplantation. Surgery 1989; 106:675684. MEDLINE
  • 4
    O'Connor TP, Lewis WD, Jenkins RL. Biliary tract complications after liver transplantation. Arch Surg 1995; 130:312317. MEDLINE
  • 5
    Williams R, Smith M, Shilkin KB, Herbertson B, Joysey V, Calne RY. Liver transplantation in man: The frequency of rejection, biliary tract complications, and recurrence of malignancy based on an analysis of 26 cases. Gastroenterology 1973; 64:10261048. MEDLINE
  • 6
    Miller WJ, Campbell WL, Zajko AB, Pinna A, Zetti G, Stieber AC, et al. Obstructive dilatation of extrahepatic recipient and donor bile ducts complicating orthotopic liver transplantation: Imaging and laboratory findings. AJR Am J Roentgenol 1991; 157:2932. MEDLINE
  • 7
    Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Buckel EG, Steers JL, et al. Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation. Hepatology 1993; 17:605609. MEDLINE
  • 8
    Colonna JO II, Shaked A, Gomes AS, Colquhoun SD, Jurim O, McDiarmid SV, et al. Biliary strictures complicating liver transplantation: Incidence, pathogenesis, management, and outcome. Ann Surg 1992; 216:344352. MEDLINE
  • 9
    Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969; 1:106112. MEDLINE
  • 10
    Jain A, Reyes J, Kashyap R, Rohal S, Cacclarelli T, McMichael J, et al. Liver transplantation under tacrolimus in infants, children, adults, and seniors: Long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc 1998; 30:14031404. MEDLINE
  • 11
    Levy M, Backman L, Husberg B, Goldstein R, McMillan R, Gibbs J, et al. De novo malignancy following liver transplantation: A single-center study. Transplant Proc 1993; 25:13971399. MEDLINE
  • 12
    Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133:173192. MEDLINE
  • 13
    Stieber AO, Boillot O, Scotti-Foglieni C, Nalesnik MA, Gordon RD, Marino I, et al. The surgical implications of the posttransplant lymphoproliferative disorders. Transplant Proc 1991; 23:14771479. MEDLINE
  • 14
    Malatack JF, Gartner JC Jr, Urbach AH, Zitelli BJ. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern. J Pediatr 1991; 118:667675. MEDLINE
  • 15
    Renard TH, Andrews WS, Foster ME. Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients. Transplant Proc 1991; 23:14731476. MEDLINE
  • 16
    Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, Lennette ET, Martinez OM, Krams SM, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995; 59:524529. MEDLINE
  • 17
    Nuckols JD, Baron PW, Stenzel TT, Olatidoye B, Tuttle-Newhall JE, Clavien P-A, Howell DN. The pathology of liver-localized post-transplant lymphoproliferative disease: A report of three cases and a review of the literature. Am J Surg Pathol 2000; 24:733741. MEDLINE
  • 18
    Moody AR, Wilson SR, Greig PD. Non-Hodgkin lymphoma in the porta hepatis after orthotopic liver transplantation: Sonographic findings. Radiology 1992; 182:867870. MEDLINE
  • 19
    Cherqui D, Duvoux C, Plassa F, Gaulard P, Julien M, Fagniez PL, et al. Lymphoproliferative disorder of donor origin in a liver transplant recipient: Complete remission after drastic reduction of immunosuppression without graft loss. Transplantation 1993; 56:10231026. MEDLINE
  • 20
    Spiro IJ, Yandell DW, Li C, Saini S, Ferry J, Powelson J, et al. Brief report: Lymphoma of donor origin occurring in the porta hepatis of a transplanted liver. N Engl J Med 1993; 329:2729. MEDLINE
  • 21
    Armes JE, Angus P, Southey MC, Battaglia SE, Ross BC, Jones RM, et al. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. Cancer 1994; 74:24362441. MEDLINE
  • 22
    Ribas Y, Rafecas A, Figueras J, Benasco C, Fabregat J, Torras J, et al. Post-transplant lymphoma in a liver allograft. Transplant Int 1995; 8:488491.
  • 23
    Strazzabosco M, Corneo B, Iemmolo RM, Menin C, Gerunda G, Bonaldi L, et al. Epstein-Barr virus-associated post-transplant lymphoproliferative disease of donor origin in liver transplant recipients. J Hepatol 1997; 26:926934. MEDLINE
  • 24
    Navarro F, Pyda P, Pageaux GP, Perrigault PF, Ramos J, Taourel P, et al. Lymphoproliferative disease after liver transplantation: Primary biliary localization. Transplant Proc 1998; 30:14861488. MEDLINE
  • 25
    McDiarmid SV, Jordan S, Lee GS, Toyoda M, Goss JA, Vargas JH, et al. Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998; 66:16041611. MEDLINE
  • 26
    Penn I. Immunosuppression—A contributory factor in lymphoma formation. Clin Transplant 1992; 6:214219.
  • 27
    Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; 1:583587. MEDLINE
  • 28
    Reyes J, Tzakis A, Green M, Nour B, Nalesnik M, Van Thiel D, et al. Posttransplant lymphoproliferative disorders occurring under primary FK506 immunosuppression. Transplant Proc 1991; 23:30443046. MEDLINE
  • 29
    Penn I. De novo cancers in organ allograft recipients. Curr Opin Organ Transplant 1998; 3:188199.
  • 30
    Penn I. The role of immunosuppression in lymphoma formation. Springer Semin Immunopathol 1998; 20:343355. MEDLINE